Table 3 Univariable analysis of predictors for DSS and MFS in patients with localized ASPS
From: Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study
Variable | N | % | 5-year DSS | p value | 5-year MFS | p value |
|---|---|---|---|---|---|---|
Age (median: years) | Â | Â | Â | 0.527 | Â | 0.947 |
 ≤ 25 years | 16 | 55% | 100% |  | 61% |  |
 > 25 years | 13 | 45% | 80% |  | 0% |  |
Sex | Â | Â | Â | 0.114 | Â | 0.240 |
 Male | 7 | 24% | 50% |  | 29% |  |
 Female | 22 | 76% | 100% |  | 21% |  |
Tumor site | Â | Â | Â | NA | Â | 0.567 |
 Lower extremity | 18 | 62% | 83% |  | 25% |  |
 Upper extremity | 4 | 14% | NA |  | 50% |  |
 Trunk | 7 | 24% | 100% |  | 0% |  |
Tumor depth | Â | Â | Â | 0.683 | Â | 0.630 |
 Superficial | 5 | 17% | 100% |  | 0% |  |
 Deep | 24 | 83% | 83% |  | 25% |  |
Tumor size | Â | Â | Â | 0.527 | Â | 0.391 |
 ≤ 5 cm | 13 | 45% | 100% |  | 76% |  |
 > 5 cm | 16 | 55% | 56% |  | 22% |  |
Type of surgery | Â | Â | Â | 0.076 | Â | 0.082 |
 Limb-salvage | 27 | 93% | 100% |  | 21% |  |
 Amputation | 1 | 3% | 0% |  | 0% |  |
 Unknown | 1 | 3% | NA |  | 0% |  |
Resection margin | Â | Â | Â | NA | Â | 0.439 |
 Intralesional | 0 | – | – |  | – |  |
 Marginal | 3 | 7% | NA |  | NA |  |
 Wide | 26 | 90% | 100% |  | 19% |  |
 Other (radical) | 1 | 3% | 0% |  | 0% |  |
RT | Â | Â | Â | NA | Â | 0.689 |
 No | 27 | 93% | 86% |  | 19% |  |
 Adjuvanta | 2 | 7% | NA |  | NA |  |
Chemotherapy | Â | Â | Â | 0.683 | Â | 0.014 |
 No | 27 | 93% | 83% |  | 20% |  |
 Neoadjuvant/adjuvantb | 2 | 7% | 100% |  | 0% |  |